Home Forums |
|
News and Events News related to bone marrow failure diseases |
|
Thread Tools | Search this Thread |
#1
|
|||
|
|||
ASH 2011 - L-Leucine Improves the Anemia of the 5q- Syndrome Via Activation of the mT
http://ash.confex.com/ash/2011/webpr...aper43073.html
970 L-Leucine Improves the Anemia of the 5q- Syndrome Via Activation of the mTOR (mammalian target of rapamycin) Pathway Good News for the 5q-Syndrome (and Patients with Diamond Blackfan Anemia): "In a case report, administration of L-Leucine to a DBA patient resulted in complete recovery of the anemia and improvement in appetite and growth parameters. We therefore hypothesized that L-Leucine could improve the anemia associated with heterozygous loss of RPS14." "Our studies support the further evaluation of L-Leucine as a potential therapeutic agent in the treatment of the 5q- syndrome."
__________________
Margarete, 54, living in Vienna, Austria, MDS/AML M2, diagnosed 9/2007, then Chemos, aSZT 4/2008, chronic GVHD |
#2
|
|||
|
|||
L-Leucine
is a food additive. Infos on wikipedia, http://en.wikipedia.org/wiki/Leucine , procuct free available (amazon.com...) Margarete
__________________
Margarete, 54, living in Vienna, Austria, MDS/AML M2, diagnosed 9/2007, then Chemos, aSZT 4/2008, chronic GVHD |
Thread Tools | Search this Thread |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
Abstract from the ASH 2011 Conference | Birgitta-A | News and Events | 7 | Tue Nov 29, 2011 12:19 PM |
ASH 2011 967 A Prognostic Model of Therapy-Related Myelodysplastic Syndrome for Predi | akita | News and Events | 2 | Sat Nov 12, 2011 05:34 PM |